Clinical trials
Osteoporosis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 2 |
| 2004 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 12 |
| Unknown status | 8 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istituto Ortopedico Rizzoli | 6 |
| Istituto Auxologico Italiano | 5 |
| Eli Lilly and Company | 4 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| University of Palermo | 3 |
| Amgen | 2 |
| I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 2 |
| IRCCS San Raffaele | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Parma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 56 |
| Bone Diseases, Metabolic | 8 |
| Osteoporosis, Postmenopausal | 7 |
| Fractures, Bone | 5 |
| Spinal Fractures | 4 |
| Hip Fractures | 3 |
| Sarcopenia | 3 |
| ACTH Syndrome, Ectopic | 2 |
| Hyperparathyroidism, Primary | 2 |
| Neoplasms | 2 |
Trials
Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.